Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000483

Drug Information
SynonymsEmconcor; Euradal; CID2405; BPBio1_000373; Bisoprolol hemifumarate; Isoten; Prestwick3_000330; 2-Propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-; Bisoprololum [Latin]; 66722-44-9; CHEMBL645; L000133; Concor; AC-18540; Monocor; EMD-33-512; Bisoprolol (USAN/INN); Soloc; Prestwick2_000330; ARONIS24082; 1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol; SBB065120; UNII-Y41JS2NL6U; NCGC00024868-04; 1-[(1-methylethyl)amino]-3-({4-[({2-[(1-methylethyl)oxy]ethyl}oxy)methyl]phenyl}oxy)propan-2-ol; Bisoprolol [USAN:BAN:INN]; 1-{4-[(2-isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)propan-2-ol; Zebeta; AKOS005110983; SPBio_002260; BSPBio_000339; C06852; EMD-33512; Bisoprolol fumerate; DB00612; D02342; Prestwick0_000330; Prestwick1_000330; C18H31NO4; Soprol; BISOPROLOL; I01-7040; Emcor; LS-122509; MolPort-005-937-320; AC1L1DLQ; NCGC00024868-02; (+-)-1-((alpha-(2-Isopropoxyethoxy)-p-tolyl)oxy)-3-(isopropylamino)-2-propanol; NCGC00024868-03; CHEBI:3127; AB00514681; Cardicor; 2-Propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-; 2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-, (.+/-.)-; Detensiel; Bisoprololum; NCGC00024868-05; (RS)-1-(4-(2-Isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol; Bisocor; CL-297939
Trade NameConcor; Zebeta; Concore; Monocor
[ICD9: 401   ICD10: I10, I11, I12, I13, I15]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntihypertensive Agents
CAS NumberCAS 66722-44-9
PubChem Compound IDCID 2405.
PubChem Substance IDSID 9070.
SuperDrug ATC IDC07AB07
SuperDrug CAS ID066722449;
TargetBeta-1 adrenergic receptorAntagonist[2][3]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Antiarrhythmic effect of bisoprolol, a highly selective beta1-blocker, in patients with paroxysmal atrial fibrillation. Int Heart J. 2008 May;49(3):281-93. To Reference
Ref 3Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation. 1994 Jun;89(6):2760-7. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543